Mithra Financial Statements From 2010 to 2026
| MITPFDelisted Stock | USD 6.75 0.00 0.00% |
Check Mithra Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mithra Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Mithra financial statements analysis is a perfect complement when working with Mithra Pharmaceuticals Valuation or Volatility modules.
Mithra |
Mithra Pharmaceuticals SA Company Return On Asset Analysis
Mithra Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mithra Pharmaceuticals Return On Asset | -0.11 |
Most of Mithra Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mithra Pharmaceuticals SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Mithra Pharmaceuticals SA has a Return On Asset of -0.1135. This is 98.7% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 18.93% lower than that of the firm.
Mithra Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mithra Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Mithra Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mithra Pharmaceuticals competition to find correlations between indicators driving Mithra Pharmaceuticals's intrinsic value. More Info.Mithra Pharmaceuticals SA is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mithra Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Mithra Pharmaceuticals Financial Statements
Mithra Pharmaceuticals stakeholders use historical fundamental indicators, such as Mithra Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Mithra Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mithra Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Mithra Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mithra Pharmaceuticals SA. Please read more on our technical analysis and fundamental analysis pages.
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Lige, Belgium. Mithra Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 300 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Mithra Pink Sheet
If you are still planning to invest in Mithra Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mithra Pharmaceuticals' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |